This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barth, H.
Right arrow Articles by Baumert, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barth, H.
Right arrow Articles by Baumert, T. F.

 Previous Article  |  Next Article 

Journal of Virology, April 2008, p. 3466-3479, Vol. 82, No. 7
0022-538X/08/$08.00+0     doi:10.1128/JVI.02478-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells{triangledown}

Heidi Barth,1,2* Eva K. Schnober,1,3,4 Christoph Neumann-Haefelin,1 Christine Thumann,3,5 Mirjam B. Zeisel,3,5 Helmut M. Diepolder,6 Zongyi Hu,2 T. Jake Liang,2 Hubert E. Blum,1 Robert Thimme,1 Mélanie Lambotin,3,5 and Thomas F. Baumert1,3,5,7*

Department of Medicine II, University of Freiburg, Freiburg, Germany,1 Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland,2 Inserm, U748, Strasbourg, France,3 Faculty of Biology, University of Freiburg, Freiburg, Germany,4 Université Louis Pasteur, Strasbourg, France,5 Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany,6 Service d'Hépatogastroentérologie, Centre Hospitalier Universitaire Strasbourg, Strasbourg, France7

Received 17 November 2007/ Accepted 11 January 2008

Class B scavenger receptors (SR-Bs) bind lipoproteins and play an important role in lipid metabolism. Most recently, SR-B type I (SR-BI) and its splicing variant SR-BII have been found to mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. In this study, we demonstrate that SR-BI is a key host factor required for hepatitis C virus (HCV) uptake and cross-presentation by human dendritic cells (DCs). Whereas monocytes and T and B cells were characterized by very low or undetectable SR-BI expression levels, human DCs demonstrated a high level of cell surface expression of SR-BI similar to that of primary human hepatocytes. Antibodies targeting the extracellular loop of SR-BI efficiently inhibited HCV-like particle binding, uptake, and cross-presentation by human DCs. Moreover, human high-density lipoprotein specifically modulated HCV-like particle binding to DCs, indicating an interplay of HCV with the lipid transfer function of SR-BI in DCs. Finally, we demonstrate that anti-SR-BI antibodies inhibit the uptake of cell culture-derived HCV (HCVcc) in DCs. In conclusion, these findings identify a novel function of SR-BI for viral antigen uptake and recognition and may have an important impact on the design of HCV vaccines and immunotherapeutic approaches aiming at the induction of efficient antiviral immune responses.


* Corresponding author. Mailing address for Heidi Barth: Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892. Phone: (301) 402-5113. Fax: (301) 402-0491. E-mail: barthh{at}niddk.nih.gov. Mailing address for Thomas F. Baumert: Inserm Unit 748, Service d'Hépatogastroentérologie, Université Louis Pasteur, 3 Rue Koeberlé, F-67000 Strasbourg, France. Phone: 33-3 90 24 37 02. Fax: 33-3 90 24 37 23. E-mail: Thomas.Baumert{at}viro-ulp.u-strasbg.fr

{triangledown} Published ahead of print on 23 January 2008.


Journal of Virology, April 2008, p. 3466-3479, Vol. 82, No. 7
0022-538X/08/$08.00+0     doi:10.1128/JVI.02478-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Mee, C. J., Harris, H. J., Farquhar, M. J., Wilson, G., Reynolds, G., Davis, C., van IJzendoorn, S. C. D., Balfe, P., McKeating, J. A. (2009). Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells. J. Virol. 83: 6211-6221 [Abstract] [Full Text]  
  • Liang, H., Russell, R. S., Yonkers, N. L., McDonald, D., Rodriguez, B., Harding, C. V., Anthony, D. D. (2009). Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells. J. Virol. 83: 5693-5707 [Abstract] [Full Text]  
  • Liu, B., Woltman, A. M., Janssen, H. L. A., Boonstra, A. (2009). Modulation of dendritic cell function by persistent viruses. J. Leukoc. Biol. 85: 205-214 [Abstract] [Full Text]  
  • Stamataki, Z., Shannon-Lowe, C., Shaw, J., Mutimer, D., Rickinson, A. B., Gordon, J., Adams, D. H., Balfe, P., McKeating, J. A. (2009). Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells. Blood 113: 585-593 [Abstract] [Full Text]